JP2010528008A5 - - Google Patents

Download PDF

Info

Publication number
JP2010528008A5
JP2010528008A5 JP2010509362A JP2010509362A JP2010528008A5 JP 2010528008 A5 JP2010528008 A5 JP 2010528008A5 JP 2010509362 A JP2010509362 A JP 2010509362A JP 2010509362 A JP2010509362 A JP 2010509362A JP 2010528008 A5 JP2010528008 A5 JP 2010528008A5
Authority
JP
Japan
Prior art keywords
tumor
stem cells
genetically modified
subject
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010509362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010528008A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/006434 external-priority patent/WO2008150368A1/en
Publication of JP2010528008A publication Critical patent/JP2010528008A/ja
Publication of JP2010528008A5 publication Critical patent/JP2010528008A5/ja
Pending legal-status Critical Current

Links

JP2010509362A 2007-05-24 2008-05-20 Ｃｄ３４幹細胞に関連した方法および組成物 Pending JP2010528008A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93162207P 2007-05-24 2007-05-24
US305007P 2007-11-14 2007-11-14
PCT/US2008/006434 WO2008150368A1 (en) 2007-05-24 2008-05-20 Cd34 stem cell-related methods and compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014007144A Division JP2014088432A (ja) 2007-05-24 2014-01-17 Ｃｄ３４幹細胞に関連した方法および組成物

Publications (2)

Publication Number Publication Date
JP2010528008A JP2010528008A (ja) 2010-08-19
JP2010528008A5 true JP2010528008A5 (enExample) 2011-07-07

Family

ID=40093981

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010509362A Pending JP2010528008A (ja) 2007-05-24 2008-05-20 Ｃｄ３４幹細胞に関連した方法および組成物
JP2014007144A Pending JP2014088432A (ja) 2007-05-24 2014-01-17 Ｃｄ３４幹細胞に関連した方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014007144A Pending JP2014088432A (ja) 2007-05-24 2014-01-17 Ｃｄ３４幹細胞に関連した方法および組成物

Country Status (11)

Country Link
US (5) US7998472B2 (enExample)
EP (4) EP2851422A3 (enExample)
JP (2) JP2010528008A (enExample)
CN (2) CN101778934B (enExample)
AU (1) AU2008260651B2 (enExample)
BR (1) BRPI0811906A2 (enExample)
CA (1) CA2688032C (enExample)
DK (1) DK2223696T3 (enExample)
ES (3) ES2430071T3 (enExample)
PL (1) PL2162534T3 (enExample)
WO (1) WO2008150368A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8574567B2 (en) 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
EP2607477B1 (en) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotent stem cells and uses thereof
US12180549B2 (en) 2007-07-23 2024-12-31 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
EP3892736A1 (en) 2007-07-23 2021-10-13 The Chinese University of Hong Kong Determining a nucleic acid sequence imbalance
CN102123717A (zh) 2008-05-27 2011-07-13 普拉里斯坦有限公司 治疗炎性结肠疾病的方法
KR20120088542A (ko) 2009-04-13 2012-08-08 아프세스 게엠베하 & 씨오. 카게 종양 치료를 위한 조작된 중간엽 줄기세포 및 이를 사용하는 방법
US20110027239A1 (en) * 2009-07-29 2011-02-03 Tissue Genesis, Inc. Adipose-derived stromal cells (asc) as delivery tool for treatment of cancer
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
EP2601956B1 (en) 2010-08-06 2017-04-12 Osaka University Islets of langerhans transplant using islets of langerhans and adipose tissue derived stem cells
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
KR102108245B1 (ko) 2011-11-30 2020-05-08 아스텔라스 인스티튜트 포 리제너러티브 메디슨 중간엽 간질 세포 및 이에 관련된 용도
US20130171115A1 (en) * 2011-12-30 2013-07-04 Gang Li Cell-mediated gene therapy for cancer using mesenchymal stem cells expressing a suicide gene
US20140369979A1 (en) * 2012-02-01 2014-12-18 Postech Academy-Industry Foundation Vector simultaneously expressing dodecameric trail and hsv-tk suicide genes, and anticancer stem cell therapeutic agent using same
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
CN104471059B (zh) 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
CA2956987C (en) 2014-08-18 2023-03-21 Apceth Gmbh & Co. Kg Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
CN104622903B (zh) * 2015-01-20 2018-10-09 奥思达干细胞有限公司 抗恶性黑色素瘤的干细胞制剂及其制备方法
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CN108884440A (zh) 2016-04-01 2018-11-23 埃普塞斯有限责任两合公司 用于增强免疫疗法的抗肿瘤活性的间充质干细胞
US20190382732A1 (en) * 2017-02-24 2019-12-19 The Board Of Regents Of The University Of Texas System Compositions and methods relating to myomixer-promoted muscle cell fusion
EP3366303B1 (en) * 2017-02-28 2020-06-24 Martin-Luther-Universität Halle-Wittenberg Enhancing the targeted in vivo delivery of cellular therapies
SG10202111394XA (en) 2017-04-13 2021-12-30 Senti Biosciences Inc Combinatorial cancer immunotherapy
US12054526B2 (en) 2018-06-15 2024-08-06 Children's Hospital Medical Center Polypeptides, nucleic acid molecules, compositions, and related methods
US11419898B2 (en) 2018-10-17 2022-08-23 Senti Biosciences, Inc. Combinatorial cancer immunotherapy
AU2019359890B2 (en) 2018-10-17 2024-10-24 Senti Biosciences, Inc. Combinatorial cancer immunotherapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514074B2 (en) * 1997-07-14 2009-04-07 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US20010038834A1 (en) * 1998-01-26 2001-11-08 Gary Balian Bone cancer therapy
US20030100107A1 (en) * 1998-05-29 2003-05-29 Thomas Jefferson University Compositions and methods for generating differentiated human cells
DE19833476B4 (de) * 1998-07-24 2005-08-25 Huss, Ralf, Dr. Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie
US20030082155A1 (en) * 1999-12-06 2003-05-01 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
EP1257282A4 (en) * 1999-12-06 2003-05-02 Gen Hospital Corp PANCREATIC STEM CELLS AND THEIR USE IN TRANSPLANTATION
CA2430653A1 (en) * 2000-11-27 2002-08-08 Yissum Research Development Company Of The Hebrew University In Jerusalem Transfection of human embryonic stem cells
DE60227519D1 (de) * 2001-06-14 2008-08-21 Takeda Pharmaceutical Neuer ligand und dna davon
WO2003010305A1 (en) 2001-07-27 2003-02-06 Arhus Amt Immortilized stem cells
US20050053587A1 (en) * 2001-09-20 2005-03-10 Jacques Galipeau Cultured stromal cells and uses thereof
WO2003087333A2 (en) * 2002-04-12 2003-10-23 Celgene Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
JP2005532810A (ja) * 2002-07-16 2005-11-04 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 組織修復および組織形成のために間葉性幹細胞を移植する方法
US20040258669A1 (en) * 2002-11-05 2004-12-23 Dzau Victor J. Mesenchymal stem cells and methods of use thereof
WO2005026335A2 (en) * 2003-09-15 2005-03-24 Ramot At Tel Aviv University Ltd. Insulin-producing bone marrow derived cells and methods of generating and using same
EP1708757A4 (en) * 2003-12-19 2007-01-17 Viacell Inc USE OF PLURIPOTENTIAL CELLS TAKEN FROM HUMAN CORDIAL BLOOD BLOOD FOR THE TREATMENT OF DISEASE
EP2298861B1 (en) * 2004-03-22 2017-09-13 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US20050233443A1 (en) * 2004-03-30 2005-10-20 Toby Freyman Restenosis therapy using mesenchymal stem cells
JP2006345726A (ja) 2005-06-14 2006-12-28 Hamamatsu Univ School Of Medicine 脳腫瘍治療用発現ベクター
KR101022401B1 (ko) * 2005-09-29 2011-03-15 아주대학교산학협력단 자살유전자를 발현하는 중간엽 줄기세포를 포함하는 암치료용 조성물

Similar Documents

Publication Publication Date Title
JP2010528008A5 (enExample)
El-Aneed Current strategies in cancer gene therapy
JP2012523243A5 (enExample)
Pol et al. Trial watch: oncolytic viruses for cancer therapy
ES2857702T3 (es) Oligonucleótidos para la reducción de la expresión de PD-L1
RU2011146048A (ru) Сконструированные мезенхимальные стволовые клетки и способ их применения для лечения опухолей
ES2806776T3 (es) Células NK-92 que expresan CAR como agentes terapéuticos celulares
Feisst et al. From bench to bedside: use of human adipose-derived stem cells
He et al. Cancer treatment evolution from traditional methods to stem cells and gene therapy
JP2015505843A5 (enExample)
Hadas et al. Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease
JP2012511545A5 (enExample)
EP3676380B1 (en) Rna nanostructures and methods of making and using rna nanostructures
Zhu et al. ShenQi FuZheng Injection ameliorates fatigue-like behavior in mouse models of cancer-related fatigue
RU2021130306A (ru) Композиции il-12, нацеленные на edb
Gong et al. Classification and characteristics of mesenchymal stem cells and its potential therapeutic mechanisms and applications against ischemic stroke
Kim et al. Stem cell based gene therapy in prostate cancer
WO2025016479A1 (zh) 核酸载体、核酸药及其制备方法和应用
Choi et al. Nano/micro-assisted regenerative medicine
JP2013530965A5 (enExample)
Jiang et al. Engineered exosomes in service of tumor immunotherapy: From optimizing tumor‐derived exosomes to delivering CRISPR/Cas9 system
ES2908854T3 (es) Método para producir un arenavirus antitumoral así como mutantes de arenavirus
Nonaka Application of engineered extracellular vesicles to overcome drug resistance in cancer
Jiang et al. Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma
Lu et al. The relationship between malignant and tumor-associated cells provides a new strategy for targeted diagnosis and therapy